Diplomat Announces 3rd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
Diplomat Pharmacy (DPLO) PT Raised to $20 at Leerink Partners
November 7, 2017 7:50 AM ESTLeerink Partners raised its price target on Diplomat Pharmacy (NYSE: DPLO) to $20.00 (from $16.00) while maintaining a Market Perform rating following mixed results.
Analyst David Larsen notes that DPLO also announced the acquisition of National Pharmaceutical Services, a PBM focused on small to mid-sized... More

